SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-060484
Filing Date
2012-11-08
Accepted
2012-11-08 17:01:29
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v324782_10q.htm 10-Q 386538
2 EXHIBIT 31.1 v324782_ex31-1.htm EX-31.1 9788
3 EXHIBIT 31.2 v324782_ex31-2.htm EX-31.2 9946
4 EXHIBIT 32.1 v324782_ex32-1.htm EX-32.1 3694
5 EXHIBIT 32.2 v324782_ex32-2.htm EX-32.2 3823
  Complete submission text file 0001144204-12-060484.txt   2705989

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kerx-20120930.xml EX-101.INS 262349
7 XBRL TAXONOMY EXTENSION SCHEMA kerx-20120930.xsd EX-101.SCH 24953
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kerx-20120930_cal.xml EX-101.CAL 36994
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kerx-20120930_def.xml EX-101.DEF 173345
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kerx-20120930_lab.xml EX-101.LAB 273151
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kerx-20120930_pre.xml EX-101.PRE 203987
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30929 | Film No.: 121190754
SIC: 2834 Pharmaceutical Preparations